Literature DB >> 11723768

Drug-induced vasculitis.

P A Merkel1.   

Abstract

DIV is a relatively common cause of inflammatory vasculitis. Drugs from almost every pharmacologic class have been implicated in causing vasculitis in sporadic cases. The level of certainty and quality of evidence for these associations between specific agents and vasculitis vary greatly. The clinical manifestations of DIV range from single organ involvement (most commonly, skin) to life-threatening multiorgan disease. The recently described subset of cases of DIV associated with positive tests for ANCA are an interesting subset of DIV. The diagnosis of DIV is usually one of exclusion. The treatment of DIV is dependent on the severity of disease activity but should always include withdrawal of the suspected drug. If no agent can be implicated, as many drugs as feasible should be discontinued. The necessity of prescribing glucocorticoids or immunosuppressive agents depends on the disease severity and other case-specific information. Increasing understanding of the pathophysiologic characteristics of all inflammatory vasculitides should lead to better diagnostic and therapeutic approaches to DIV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723768     DOI: 10.1016/s0889-857x(05)70239-8

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  13 in total

Review 1.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

Review 2.  Drug-induced glomerular disease: attention required!

Authors:  Jai Radhakrishnan; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-15       Impact factor: 8.237

Review 3.  Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Authors:  Marco A Alba; J Charles Jennette; Ronald J Falk
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

4.  Propylthiouracil-associated rapidly progressive crescentic glomerulonephritis with double positive anti-glomerular basement membrane and antineutrophil cytoplasmic antibody: the first case report.

Authors:  Pitchaporn Kantachuvesiri; Panas Chalermsanyakorn; Bunyong Phakdeekitcharoen; Thitima Lothuvachai; Kannika Niticharoenpong; Piyanuch Radinahamed; Neil Turner; Surasak Kantachuvesiri
Journal:  CEN Case Rep       Date:  2014-12-31

5.  Propylthiouracil-induced autoimmune syndromes: 11 case report.

Authors:  Rui Wu; Rongheng Li
Journal:  Rheumatol Int       Date:  2010-12-07       Impact factor: 2.631

6.  Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement.

Authors:  Albert Hing Wong; Wei-Kei Wong; Lai-Meng Looi; Jeyakantha Ratnasingam; Soo-Kun Lim
Journal:  Case Rep Nephrol Dial       Date:  2022-06-17

Review 7.  Vasculitis induced by tumor necrosis factor-targeted therapies.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

8.  Successful drug development despite adverse preclinical findings part 2: examples.

Authors:  Robert A Ettlin; Junji Kuroda; Stephanie Plassmann; Makoto Hayashi; David E Prentice
Journal:  J Toxicol Pathol       Date:  2010-12-16       Impact factor: 1.628

9.  Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK.

Authors:  Pirunthan Pathmarajah; Karishma Shah; Kathy Taghipour; Su Ramachandra; Mangesh A Thorat; Ziaullah Chaudhry; Vivek Patkar; Francesca Peters; Thomas Connor; Emma Spurrell; Jeffrey S Tobias; Jayant S Vaidya
Journal:  Int J Surg Case Rep       Date:  2015-09-26

Review 10.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.